Young Black Pharma
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2022 | 70,106 | 49,084 | 21,022 | 5.0 | — |
| 2023 | 389,049 | 244,141 | 144,908 | 8.1 | 0% |
In its most recent public year (2023), this organization brought in $144,908 more than it spent. Its reserves stood at about 8.1 months of spending, up from 5 in 2022. Staff pay was 0% of spending. $89,084 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Young Black Pharma's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works